Back
Acrivon Therapeutics Stock Price Chart
Could This Stock Under $5 Be Your Biggest Opportunity?
Click here to learn more.
Sell
37
ACRV
Acrivon Therapeutics
Last Price:
$6.60
Seasonality Move:
28.76%
7 Day Trial
ALL ACCESS PASS
$
7
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
The current trend is relatively stagnant and ACRV is experiencing buying pressure, which is a positive indicator for future bullish movement.
Acrivon Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 6.06 | Buy |
| 20-day SMA: | 6.54 | Buy |
| 50-day SMA: | 7.19 | Sell |
| 200-day SMA: | 7.67 | Sell |
| 8-day EMA: | 6.18 | Buy |
| 20-day EMA: | 6.48 | Buy |
| 50-day EMA: | 6.95 | Sell |
| 200-day EMA: | 7.45 | Sell |
Acrivon Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.32 | Sell |
| Relative Strength Index (14 RSI): | 49.99 | Sell |
| Chaikin Money Flow: | 57973 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (6.13 - 7.27) | Sell |
| Bollinger Bands (100): | (6.64 - 8.5) | Sell |
Acrivon Therapeutics Technical Analysis
| Dec 19 | Dec 20 | Dec 23 | Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 19 | 20 | 23 | 24 | 26 | 27 | 30 | 31 | 02 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Acrivon Therapeutics Stock
Is Acrivon Therapeutics Stock a Buy?
-
Acrivon Therapeutics share price is 6.62 while ACRV 8-day simple moving average is 6.06, which is a Buy signal.
-
The stock price of ACRV is 6.62 while Acrivon Therapeutics 20-day SMA is 6.54, which makes it a Buy.
-
Acrivon Therapeutics 50-day simple moving average is 7.19 while ACRV share price is 6.62, making it a Sell technically.
-
ACRV stock price is 6.62 and Acrivon Therapeutics 200-day simple moving average is 7.67, creating a Sell signal.
ACRV Technical Analysis vs Fundamental Analysis
Sell
37
Acrivon Therapeutics (ACRV)
is a Sell
Is Acrivon Therapeutics a Buy or a Sell?
-
Acrivon Therapeutics stock is rated a SellThe current Acrivon Therapeutics [ACRV] share price is $6.62. The Score for ACRV is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
Acrivon Therapeutics Stock Info
Market Cap:
206.1M
Price in USD:
6.62
Share Volume:
70K
Acrivon Therapeutics 52-Week Range
52-Week High:
11.90
52-Week Low:
3.19
Sell
37
Acrivon Therapeutics (ACRV)
is a Sell
Acrivon Therapeutics Share Price Forecast
-
What is the Acrivon Therapeutics stock price today?The Acrivon Therapeutics stock price is 6.62 USD today.
-
Will ACRV stock go up or go down?Acrivon Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Acrivon Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Acrivon Therapeutics is overvalued.
Is Acrivon Therapeutics Stock a Buy?
-
Acrivon Therapeutics share price is 6.62 while ACRV 8-day exponential moving average is 6.18, which is a Buy signal.
-
The stock price of ACRV is 6.62 while Acrivon Therapeutics 20-day EMA is 6.48, which makes it a Buy.
-
Acrivon Therapeutics 50-day exponential moving average is 6.95 while ACRV share price is 6.62, making it a Sell technically.
-
ACRV stock price is 6.62 and Acrivon Therapeutics 200-day simple moving average is 7.45, creating a Sell signal.
Fundamental Analysis of Acrivon Therapeutics
Is Acrivon Therapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.29 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.33 per share, and an increase next year of $0.24 per share.
Technical Analysis of Acrivon Therapeutics
Should I short Acrivon Therapeutics stock?
-
ACRV Moving Average Covergence Divergence (MACD) indicator is -0.32, suggesting Acrivon Therapeutics is a Sell
-
Acrivon Therapeutics Relative Strength Index (RSI) is 49.99, which suggest Acrivon Therapeutics is oversold
-
The Bollinger Bands (25) for Acrivon Therapeutics is (6.13 - 7.27), which suggest Acrivon Therapeutics is a Sell
-
The Bollinger Bands (100) for Acrivon Therapeutics is (6.64 - 8.5), which suggest Acrivon Therapeutics is a Sell
* Acrivon Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.